US GAO says FDA needs further progress on overseas activities
This article was originally published in RAJ Devices
Executive Summary
A US government watchdog says that the opening of the Food and Drug Administration's overseas offices has resulted in some immediate benefits, although it is still too early to gauge the impact the offices have had on the safety of imported medical devices and other FDA-regulated products1.